294 related articles for article (PubMed ID: 33287301)
1. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.
Velasco-de Andrés M; Casadó-Llombart S; Català C; Leyton-Pereira A; Lozano F; Aranda F
Cells; 2020 Dec; 9(12):. PubMed ID: 33287301
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors
Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Lozano F; Bosch E
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070159
[TBL] [Abstract][Full Text] [Related]
3. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
[TBL] [Abstract][Full Text] [Related]
4. The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells.
Gimferrer I; Farnós M; Calvo M; Mittelbrunn M; Enrich C; Sánchez-Madrid F; Vives J; Lozano F
J Biol Chem; 2003 Mar; 278(10):8564-71. PubMed ID: 12473675
[TBL] [Abstract][Full Text] [Related]
5. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
Gonçalves CM; Henriques SN; Santos RF; Carmo AM
Front Immunol; 2018; 9():2994. PubMed ID: 30619347
[TBL] [Abstract][Full Text] [Related]
6. A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.
Breuning J; Brown MH
Immunology; 2019 Mar; 156(3):270-276. PubMed ID: 30460991
[TBL] [Abstract][Full Text] [Related]
7. Relevance of CD6-mediated interactions in T cell activation and proliferation.
Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
[TBL] [Abstract][Full Text] [Related]
8. OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation.
Castro MA; Nunes RJ; Oliveira MI; Tavares PA; Simões C; Parnes JR; Moreira A; Carmo AM
J Leukoc Biol; 2003 Jan; 73(1):183-90. PubMed ID: 12525577
[TBL] [Abstract][Full Text] [Related]
9. The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation.
Mori D; Grégoire C; Voisinne G; Celis-Gutierrez J; Aussel R; Girard L; Camus M; Marcellin M; Argenty J; Burlet-Schiltz O; Fiore F; Gonzalez de Peredo A; Malissen M; Roncagalli R; Malissen B
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33125054
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domain.
Rodamilans B; Muñoz IG; Bragado-Nilsson E; Sarrias MR; Padilla O; Blanco FJ; Lozano F; Montoya G
J Biol Chem; 2007 Apr; 282(17):12669-77. PubMed ID: 17322294
[TBL] [Abstract][Full Text] [Related]
11. Interactome analysis of CD5 and CD6 ectodomains with tegumental antigens from the helminth parasite Echinococcus granulosus sensu lato.
Miles S; Velasco-de-Andrés M; Lozano F; Mourglia-Ettlin G
Int J Biol Macromol; 2020 Dec; 164():3718-3728. PubMed ID: 32891642
[TBL] [Abstract][Full Text] [Related]
12. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
13. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
14. Pattern Recognition by CD6: A Scavenger-Like Lymphocyte Receptor.
Sarukhan A; Martinez-Florensa M; Escoda-Ferran C; Carrasco E; Carreras E; Lozano F
Curr Drug Targets; 2016; 17(6):640-50. PubMed ID: 25777272
[TBL] [Abstract][Full Text] [Related]
15. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.
Soldevila G; Raman C; Lozano F
Curr Opin Immunol; 2011 Jun; 23(3):310-8. PubMed ID: 21482089
[TBL] [Abstract][Full Text] [Related]
16. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.
Hassan NJ; Simmonds SJ; Clarkson NG; Hanrahan S; Puklavec MJ; Bomb M; Barclay AN; Brown MH
Mol Cell Biol; 2006 Sep; 26(17):6727-38. PubMed ID: 16914752
[TBL] [Abstract][Full Text] [Related]
17. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
18. CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies.
Aragón-Serrano L; Carrillo-Serradell L; Planells-Romeo V; Isamat M; Velasco-de Andrés M; Lozano F
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139340
[TBL] [Abstract][Full Text] [Related]
19. CD6 as a therapeutic target in autoimmune diseases: successes and challenges.
Pinto M; Carmo AM
BioDrugs; 2013 Jun; 27(3):191-202. PubMed ID: 23568178
[TBL] [Abstract][Full Text] [Related]
20. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]